daunorubicin has been researched along with B16 Melanoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atassi, G; Baron, M; Bissery, MC; Cros, S; Gebel-Servolles, P; Giorgi-Renault, S; Lavelle, F; Paoletti, C; Renault, J | 1 |
| Contente, TC; Filippin-Monteiro, FB; Kretzer, IF; Maranhão, RC; Maria, DA | 1 |
| Bijsterbosch, MK; Rensen, PC; Rump, ET; Van Berkel, TJ; Versluis, AJ | 1 |
| Egawa, K; Seo, N; Takigawa, M; Tokura, Y | 1 |
| Basu, SK; Mukhopadhyay, A; Mukhopadhyay, B; Srivastava, RK | 1 |
| Borgert, CJ; Kroll, DJ; Rowe, TC; Wiedmann, TW | 1 |
| Bjerring, P; Buchardt, O; Langkjer, ST; Langvad, E; Wätjen, F; Wirth, M | 1 |
| Acton, EM; Filppi, JA; Taylor, DL; Tong, GL; Wolgemuth, RL | 1 |
8 other study(ies) available for daunorubicin and B16 Melanoma
| Article | Year |
|---|---|
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
Topics: Animals; Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Female; Humans; Leukemia L1210; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Structure; Neoplasms, Experimental; Quinazolines; Sarcoma, Experimental; Structure-Activity Relationship | 1991 |
Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Cholesterol; Daunorubicin; Drug Carriers; Drug Stability; Emulsions; Male; Melanoma, Experimental; Mice, Inbred C57BL; Molecular Structure; Nanostructures; Neoplasm Transplantation; Oleic Acids; Particle Size; Protein Binding; Receptors, LDL; Toxicity Tests, Acute | 2014 |
Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.
Topics: Animals; Antibiotics, Antineoplastic; Apolipoproteins E; Binding, Competitive; Calcium; Daunorubicin; Drug Carriers; Liposomes; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Protein Binding; Receptors, LDL; Solubility; Tumor Cells, Cultured | 1998 |
Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Antibody Specificity; Carcinoma, Hepatocellular; Cytokines; Cytotoxicity, Immunologic; Daunorubicin; Interleukin-10; Killer Cells, Natural; Lymphocyte Depletion; Lymphocytes, Tumor-Infiltrating; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Receptors, Antigen, T-Cell, gamma-delta; Suppressor Factors, Immunologic; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |
Scavenger-receptor-mediated delivery of daunomycin elicits selective toxicity towards neoplastic cells of macrophage lineage.
Topics: Albumins; Animals; Cell Transformation, Neoplastic; CHO Cells; Cricetinae; Cricetulus; Daunorubicin; Iodine Radioisotopes; Ligands; Macrophages; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Serum Albumin, Bovine; Tumor Cells, Cultured | 1992 |
Drug sensitivity of heat-resistant mouse B16 melanoma variants.
Topics: Acclimatization; Animals; Antineoplastic Agents; Cell Line; Daunorubicin; DNA, Neoplasm; DNA, Single-Stranded; Doxorubicin; Drug Tolerance; Etoposide; Genetic Variation; Hot Temperature; In Vitro Techniques; Melanoma, Experimental; Mice; Tumor Cells, Cultured | 1990 |
Synthesis, tissue distribution and cytostatic properties of two new daunorubicin derivatives of 2-thiouracil containing a guanidine bridge.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Guanidines; Injections, Intramuscular; Male; Melanoma, Experimental; Mice; Mice, Inbred DBA; Thiouracil; Tissue Distribution; Tumor Cells, Cultured | 1986 |
New cyanomorpholinyl byproduct of doxorubicin reductive alkylation.
Topics: Alkylation; Animals; Daunorubicin; DNA Replication; Doxorubicin; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Oxidation-Reduction; Structure-Activity Relationship | 1986 |